Obesity: novel and unusual predisposing factors
- PMID: 32489583
- PMCID: PMC7238298
- DOI: 10.1177/2042018820922018
Obesity: novel and unusual predisposing factors
Abstract
To tackle the complexity of the global obesity epidemic, it is important to consider the many predisposing factors that underlie progressive and sustained weight gain. Some of the biological drivers for weight gain following initial weight loss include persistent changes in appetite hormones [including ghrelin and postprandial plasma peptide YY (PYY)], and 'persistent metabolic adaptation'. However, many factors within our busy, stressful modern-day environment seem to conspire towards promotion of weight gain. These include the effects of sleep deprivation on appetite regulation, and the effects of modern-day technology on 'attention competition'. These factors, combined with cultural and societal factors can result in a 'mindless' attitude regarding eating-related behaviour that is likely to predispose to weight gain. In addition to the external environment, our internal environment within the gut has also changed radically within the last few decades, resulting from changes in fibre intake, and increased ingestion of highly refined, sterilised and processed foods. Although contentious, these dietary changes have implications for our gut microbiota, and possible downstream effects on control of appetite and metabolism. In this brief review, we consider some of the novel predisposing factors for weight gain within our modern-day 21st century environments (both external and internal), and explore how legal terminology can help to conceptualise the numerous factors that contribute towards weight gain, and, ultimately the global obesity epidemic.
Keywords: actus reus; manner; mens rea; obesity.
© The Author(s), 2020.
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
Figures
References
-
- Barber TM, McCarthy MI, Wass JA, et al. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 2006; 65: 137–145. - PubMed
-
- Saboor Aftab SA, Kumar S, Barber TM. The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism. Clin Endocrinol (Oxf) 2013; 78: 330–337. - PubMed
-
- Barber TM, McCarthy MI, Franks S, et al. Metabolic syndrome in polycystic ovary syndrome. Endokrynol Pol 2007; 58: 34–41. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
